Eagle Asset Management Inc Amicus Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $14.1 Million - $17.3 Million	-1,616,670 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $8.08 Million - $21 Million	-878,434 Reduced 35.21%	1,616,670 $16.3 Million
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $3.68 Million - $6.81 Million	-273,405 Reduced 9.88%	2,495,104 $57.6 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $152,810 - $188,375	-11,855 Reduced 0.43%	2,768,509 $39 Million
Q2 2020 Aug 12, 2020	SELL	$8.86 - $15.69 $449,113 - $795,326	-50,690 Reduced 1.79%	2,780,364 $43.2 Million
Q1 2020 May 11, 2020	BUY	$6.63 - $11.16 $582,472 - $980,450	87,854 Added 3.2%	2,831,054 $26.2 Million
Q4 2019 Feb 07, 2020	SELL	$7.48 - $10.75 $190,440 - $273,695	-25,460 Reduced 0.92%	2,743,200 $26.7 Million
Q3 2019 Nov 04, 2019	BUY	$8.02 - $13.25 $411,105 - $679,195	51,260 Added 1.89%	2,768,660 $22.2 Million
Q2 2019 Aug 05, 2019	BUY	$10.96 - $14.4 $1.14 Million - $1.5 Million	104,042 Added 3.98%	2,717,400 $33.9 Million
Q1 2019 May 01, 2019	BUY	$10.04 - $13.92 $700,832 - $971,671	69,804 Added 2.74%	2,613,358 $35.5 Million
Q4 2018 Feb 11, 2019	BUY	$8.38 - $13.44 $20,606 - $33,048	2,459 Added 0.1%	2,543,554 $24.4 Million
Q3 2018 Nov 08, 2018	SELL	$11.6 - $16.54 $41,528 - $59,213	-3,580 Reduced 0.14%	2,541,095 $30.7 Million
Q2 2018 Aug 07, 2018	SELL	$13.13 - $17.09 $1.36 Million - $1.77 Million	-103,502 Reduced 3.91%	2,544,675 $39.7 Million
Q1 2018 May 09, 2018	SELL	$13.76 - $17.12 $183,475 - $228,278	-13,334 Reduced 0.5%	2,648,177 $39.8 Million
Q4 2017 Feb 09, 2018	SELL	$12.51 - $16.24 $462,757 - $600,733	-36,991 Reduced 1.37%	2,661,511 $38.6 Million
Q3 2017 Nov 09, 2017	BUY	$11.74 - $15.78 $31.7 Million - $42.6 Million	2,698,502	2,698,502 $40.5 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$275 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$268 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$233 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$229 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$221 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.68B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account